Applied DNA Sciences (APDN) Closes $5M Private Placement; Allocate Proceeds to Continued Market Growth

QualityStocks would like to highlight Applied DNA Sciences, Inc. (OTCBB: APDN). The company sells patented DNA security solutions to protect products, brands, and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied, providing a forensic chain of evidence that can be used to prosecute perpetrators.

In the company’s news yesterday,

Applied DNA Sciences announced the closing of a $5.0 million institutional round of financing through a private placement sale of its common stock.

In recent months, Applied DNA’s business strategy was to enhance its product line and attract new employees, customers and partners, which resulted in growing demand for the company’s solutions and a subsequent increase in revenues. The additional capital will be used to fully utilize the company’s market opportunities and to leverage continued company growth and development.

“Raising our first round of institutional capital in this economic environment is a true testament to the hard work of our team,” Dr. James Hayward, president and CEO of Applied DNA stated in the press release. “In a time of extraordinary market pressure, we are steadily growing and redefining what customers expect from security technology solutions.”

With the closing of this round, Gerald Catenacci of Neustrada Capital, one of two investors contributing a majority of the funding, will join the company’s board of directors within 30 days after closing this round of financing.

“[Applied DNA] is well poised to dominate the demand for source authentication,” Catenacci stated. “We are confident the company will continue to add key accounts, satisfy marquee customers, and integrate technologies into multiple industry verticals.”

John Bitzer, III of Abarta, the other majority investor, will also join the Applied DNA’s board, and voiced his confidence in the company’s ability to continue to grow its value.

“Abarta welcomed the opportunity to add to its current investment in [Applied DNA] because we believe that this funding will allow [Applied DNA] to build on its tremendous momentum and secure its place at the forefront of security solutions companies,” Bitzer stated.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.